Literature DB >> 31281965

A real-life experience of psoriatic patients with history of cancer treated with biological drugs.

G Odorici1, C Lasagni1, L Bigi1, G Pellacani1, A Conti1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31281965     DOI： 10.1111/jdv.15775

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  2 in total

1.  TNF-alpha inhibitors and ustekinumab for the treatment of psoriasis: therapeutic utility in the era of IL-17 and IL-23 inhibitors.

Authors:  Julie J Hong; Edward K Hadeler; Megan L Mosca; Nicholas D Brownstone; Tina Bhutani; Wilson J Liao
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2022-01-12

2.  Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study.

Authors:  Cristina Pellegrini; Maria Esposito; Giovanni Schinzari; Maria Concetta Fargnoli; Ernesto Rossi; Paolo Gisondi; Stefano Piaserico; Paolo Dapavo; Andrea Conti; Alessio Gambardella; Martina Burlando; Alessandra Narcisi; Annamaria Offidani; Riccardo Balestri; Federico Bardazzi; Francesca Prignano; Cristina Mugheddu; Marco Romanelli; Giovanna Malara
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.